The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients

The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients

Copyright © 2018 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 192(2018) vom: 05. Juli, Seite 85-91
1. Verfasser: Sthoeger, Zev (VerfasserIn)
Weitere Verfasser: Sharabi, Amir, Asher, Ilan, Zinger, Heidy, Segal, Rafael, Shearer, Gene, Elkayam, Ori, Mozes, Edna
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Cytokines Immunomodulation of gene expression Indoleamine 2,3-dioxygenase (IDO) Primary Sjogren's syndrome (pSS) Tolerogenic peptide (hCDR1) Antibodies, Monoclonal FOXP3 protein, human Forkhead Transcription Factors Immunologic Factors mehr... Peptide Fragments Peptides Transforming Growth Factor beta edratide 38PLP07BKC
Online verfügbar Volltext